THE PRESENT INVENTION RELATES TO A PHARMACEUTICAL DOSAGE FORM CONTAINING THE ACTIVE SUBSTANCE BIBW 2992 AS THE DIMALEATE SALT, PROVIDING AN IMMEDIATE RELEASE PROFILE OF THE ACTIVE SUBSTANCE, FURTHER, THE INVENTION RELATES TO COMPACTED INTERMEDIATES COMPRISING BIBW 2992 DIMALEATE SALT (BIBW 2992 MA2) IN FORM OF A POWDER PREPARED USING A COMBINED ROLLER COMPACTION AND SIEVING STEP FROM BIBW 2992 MA2, INTERMEDIATE BLENDS PREPARED FROM SAID COMPACTED INTERMEDIATE AS WELL AS SOLID ORAL FORMULATIONS PROVIDING AN IMMEDIATE RELEASE PROFILE OF THE ACTIVE SUBSTANCE, MADE FROM SAID COMPACTED INTERMEDIATE OR FROM SAID INTERMEDIATE BLENDS READY FOR USE/INGESTION, E.G. CAPSULE AND TABLET FORMULATIONS SUCH AS UNCOATED OR FILM-COATED TABLETS PREPARED BY DIRECT-COMPRESSION, AND METHODS FOR THEIR PRODUCTION. (NO SUITABLE FIGURE)
